📈 HSI Surpasses 26,000! NetEase ATH, 11 Stocks Doubled – Still Have Chance? The Hang Seng Index (HSI) has finally done what few thought possible just a year ago: break 26,000, its highest level in four years. The rally isn’t just index-level strength — it’s a broad-based surge, with 11 HSI constituents doubling in value so far in 2025. At the front of the pack, Tencent (0700.HK) closed at HK$633, its highest in three years, while NetEase (NTES.US) just printed a fresh U.S.-listed record high at $145. Consumer names and financials are joining the party too — Pop Mart (+222.8%), Sino Biopharm (+181.9%), and Chow Tai Fook (+146.4%) highlight how wide the rally has spread. The question buzzing across trading floors (and Tiger’s community): is this momentum just getting started, or are we danci

Most HKEX blue chips stocks are under value less than 1 P/B so they are currently going thru reversal to the mean of catching up to reasonable valuations 

The Hang Seng Index (HSI) has smashed through 26,000 points to 26,150.73, hitting a 4-year high, fueled by a China market resurgence. Tencent closed at HK$633, a 3-year peak with a 51.67% YTD gain, while NetEase (NTES) U.S. shares hit $145, an all-time high with a 38% surge. Standouts include Xiaomi up 62.90%, China Life Insurance up 58.79%, HSBC up 41.67%, Pop Mart up 222.80%, Sino Biopharmaceutical up 181.97%, and Chow Tai Fook Jewellery up 146.39%, with 11 HSI constituents doubling this year. The S&P 500 sits at 6,520.34, Nasdaq at 21,950, and Bitcoin at $123,456, with the VIX at 14.10 and oil at $74.50/barrel amid tariff talks. Posts found on X cheer “China bull run” but flag “overheating risks.” Are you bullish on this record rally? Beyond Alibaba and Tencent, which tech stocks ca

$HSI(HSI)$ The Hang Seng Index (HSI) has reclaimed a level it has not seen since 2021, breaking through the 26,000-point barrier and marking a decisive four-year high. For a market that had been written off by many global investors as “uninvestable,” the rally signals a dramatic shift in sentiment. Not only has the index as a whole gained momentum, but individual constituents are delivering staggering returns. Eleven Hang Seng Index stocks have doubled in value this year, and several blue-chip giants have reclaimed multi-year highs. Tencent closed at HK$633, its strongest level in three years, while NetEase’s U.S.-listed shares reached $145, an all-time record. With China’s tech, consumer, and financial sectors driving the rally, investors are aski

The Hang Seng Index has reached 26,000 points, marking a 4-year high. $TENCENT(00700)$ closed at HK$633, hitting a 3-year high, while $NetEase(NTES)$ climbed to $145, a record high.Boosted by the rise of AI large models, the gaming industry is being revalued. With cost reduction and efficiency gains, future games are expected to become more sophisticated—and even more effective at driving in-game spending.Among Hang Seng Index constituents: $XIAOMI-W(01810)$ is up 62.90%, $CHINA LIFE(02628)$ is up 58.79%, $TENCENT(00700)$ is up 51.67%,

long put

long call

I will still hold my stock in SGX. Singapore is much more save country.

Buy directly from HK market of course, which I had done so! More liqudity SGX is mostly died

I started trading HK option pretty interesting very similar to US option. But got my first shock as the lot size is totally different. Now already get use to cautiously look at lot size before any other things. Happy trading HK here I come....

Direct HK stocks usually offer deeper liquidity, tighter spreads, and better alignment with China’s economic cycle. However, they carry FX risk (HKD/USD peg) and higher volatility. SDRs in SG provide convenience, SGD settlement, and possibly easier tax handling, but liquidity can be limited, and spreads wider. For long-term bullish exposure, LEAP calls on HK names can be attractive due to leverage and capped downside, but risks include: time decay if recovery is slow, regulatory shocks, and low option liquidity. If conviction is very strong and you can tolerate volatility, a barbell approach (core HK equity + selective LEAPs) may balance risk and upside. 👉 Prudent investors usually mix direct equity (for staying power) with limited derivative exposure (for leverage).

I prefer to buy China exposure through HK stocks directly rather than SDRs listed in SG, but I won't buy LEAP calls on HK names as it is too risky for me.

I feel direct ownership gives me more piece of mind rather than SDRs

no but bought some China stocks as growing

I'd buy HK Stocks, but not Leap Calls.

I would lean towards buying China exposure through HK stocks listed locally or via SGX SDRs depending on ease and capital efficiency. HK SDRs offer a lower minimum investment, simpler access in SGD, and avoid cross-border complexities compared to directly buying HK shares. This makes them appealing for retail investors seeking bite-sized exposure to major China plays like Alibaba, Tencent, and BYD. For long-term bullishness, LEAP calls on HK names could also be attractive to leverage strong growth prospects, especially given recent strong inflows and positive outlooks from Goldman Sachs and Standard Chartered. However, LEAP calls carry higher risk and require careful timing and market conviction. Using a mix of HK SDRs for core exposure and selective LEAPS for upside could be a balanced ap